Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.

Author: JiangTeng, MengXiang-Fei, TanChen-Chen, TanLan, TanMeng-Shan, WangChong, WangHui-Fu, YuJin-Tai, ZhuXi-Chen

Paper Details 
Original Abstract of the Article :
BACKGROUND: Research into Ginkgo biloba has been ongoing for many years, while the benefit and adverse effects of Ginkgo biloba extract EGb761 for cognitive impairment and dementia has been discussed controversially. OBJECTIVE: To discuss new evidence on the clinical and adverse effects of standard...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.3233/JAD-140837

データ提供:米国国立医学図書館(NLM)

Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review

The desert of cognitive decline and dementia can be a daunting and isolating journey for individuals and their families. Ginkgo biloba, a natural remedy, has garnered attention for its potential cognitive-enhancing effects. This systematic review and meta-analysis evaluate the efficacy and safety of standardized Ginkgo biloba extract EGb761 for cognitive impairment and dementia. The study suggests that EGb761 at a dose of 240 mg/day may help stabilize or slow cognitive decline, particularly in patients with neuropsychiatric symptoms. The review also emphasizes the overall safety profile of EGb761.

A Potential Oasis in the Desert of Cognitive Decline

The findings offer a glimmer of hope for individuals seeking natural remedies for cognitive impairment and dementia. While further research is needed to fully understand the long-term effects and optimal dosage of EGb761, this study suggests that it may hold promise as a complementary approach to managing cognitive decline. However, it's important to note that EGb761 should not be considered a substitute for conventional medical treatment.

Navigating the Desert of Cognitive Decline: A Patient's Perspective

As an individual experiencing cognitive decline or caring for a loved one with dementia, exploring natural remedies can be a source of hope and empowerment. This review provides a valuable overview of the current evidence base for Ginkgo biloba, encouraging you to have open discussions with your healthcare team about potential complementary therapies.

Dr. Camel's Conclusion

The desert of cognitive decline can be a challenging journey. This systematic review offers a glimpse into the potential benefits of Ginkgo biloba extract EGb761 as a natural remedy for cognitive impairment and dementia. While further research is needed, the findings offer a potential oasis of hope for those seeking complementary approaches to managing cognitive decline.

Date :
  1. Date Completed 2015-07-06
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25114079

DOI: Digital Object Identifier

10.3233/JAD-140837

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.